Cingulate Therapeutics

1 follower

‌

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Pharmaceutical

Headquarters

Kansas City, United States

Employees

11-50

Links

Org chart

Shane J. Schaffer

Chairman & CEO

Shane J. Schaffer

Collapse

Raul R. Silva

Chief Science Officer

Matthew Brams

Chief Medical Officer

Arthur Straughn

Co-founder Board of Directors

Jeff Bennett

Deputy General Counsel

Naama Courtemanche

Vp, Operations And Quality Assurance

Thomas Dalton

Vice President, Investor & Public Relations; Vice President, Government Affairs

Jennifer Callahan

Svp, Chief Financial Officer

Teams

Advisory Team

11 members

Leadership Team

3 members

Operations and Administration

4 members

Similar companies

Bristol-Myers Squibb

175 followers

Walgreens Boots Alliance

105 followers

Syneos Health

17 followers

Parexel

6 followers

AbbVie

166 followers

SmithRx

3 followers

Esperion Therapeutics

2 followers

Amgen

198 followers

Aspen Surgical

1 follower

Providence Medical Technology

1 follower

Kandji

7 followers

Explore companies